ANTENGENE-B News

ANTENGENE-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024

Apr 3 04:53 ET

ANTENGENE-B: ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2023 AND PROPOSED AMENDMENTS TO THE EXISTING MEMORANDUM AND ARTICLES OF ASSOCIATION AND ADOPTION OF THE NEW MEMORANDUM AND ARTICLES OF ASSOCIATION AND CHANGE IN USE OF PROCEEDS

Mar 22 05:59 ET

ANTENGENE-B: ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2023 AND PROPOSED AMENDMENTS TO THE EXISTING MEMORANDUM AND ARTICLES OF ASSOCIATION AND ADOPTION OF THE NEW MEMORANDUM AND ARTICLES OF ASSOCIATION AND CHANGE IN USE OF PROCEEDS

Mar 22 04:41 ET

ANTENGENE-B: NOTICE OF DATE OF BOARD MEETING

Mar 11 04:30 ET

ANTENGENE-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024

Mar 4 03:08 ET

ANTENGENE-B: Notification Letter and Reply Form to Non-registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications

Feb 26 03:35 ET

ANTENGENE-B: Notification Letter and Reply Form to Registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications

Feb 26 03:30 ET

ANTENGENE-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024

Feb 1 03:25 ET

ANTENGENE-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023

Jan 4 03:25 ET

ANTENGENE-B: VOLUNTARY ANNOUNCEMENT SELINEXOR (XPOVIO), ANTENGENE''S FIRST-IN-CLASS NEW DRUG, SUCCESSFULLY INCLUDED IN 2023 NATIONAL REIMBURSEMENT DRUG LIST

Dec 13, 2023 17:50 ET

ANTENGENE-B: VOLUNTARY ANNOUNCEMENT APPROVAL OF NDA BY THE PHARMACEUTICAL ADMINISTRATION BUREAU OF MACAU FOR ATG-010 (SELINEXOR) FOR THE TREATMENT OF RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA

Dec 6, 2023 03:30 ET

ANTENGENE-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2023

Dec 5, 2023 03:25 ET

ANTENGENE-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2023

Nov 3, 2023 04:25 ET

ANTENGENE-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2023

Oct 5, 2023 04:25 ET

ANTENGENE-B: NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED SHAREHOLDERS

Sep 27, 2023 04:54 ET

ANTENGENE-B: 2023 INTERIM REPORT

Sep 27, 2023 04:53 ET

ANTENGENE-B: VOLUNTARY ANNOUNCEMENT UNUSUAL PRICE AND TRADING VOLUME MOVEMENT

Sep 17, 2023 20:08 ET

ANTENGENE-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2023

Sep 5, 2023 05:51 ET

ANTENGENE-B: ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED JUNE 30, 2023

Aug 25, 2023 04:30 ET

ANTENGENE-B: NOTICE OF DATE OF BOARD MEETING

Aug 14, 2023 18:12 ET